Want to join the conversation?
$MKC 2Q15 Call – Gordon, CFO: We expect our cost reduction & pricing activity to continue to improve gross profit margin. We expect gross profit margin for FY15 to be comparable to FY14, rather than up slightly. As percentage of net sales, our SG&A expense declined 60BP;& special charges of $19MM in 2Q15 related to additional actions planned EMEA.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.